Safe Stool Softeners During Breastfeeding
Docusate (docusate sodium) is the safest stool softener for breastfeeding mothers, as it is not absorbed systemically and therefore does not enter breast milk in significant amounts.
First-Line Recommendation: Non-Absorbed Agents
The safest approach to treating constipation while breastfeeding is to use non-absorbed laxatives and stool softeners as first-line therapy 1. These agents work locally in the gastrointestinal tract and have minimal to no systemic absorption, making them ideal for lactating women.
Docusate (Stool Softener)
- Docusate sodium is a stool softener that works by allowing water and fats to penetrate the stool
- It is poorly absorbed from the gastrointestinal tract
- Minimal to no transfer into breast milk occurs
- Has been used safely in postpartum women, including those who sustained obstetric anal sphincter injuries 2
- No adverse effects reported in breastfed infants
Second-Line Options: Osmotic Laxatives
If a stool softener alone is insufficient, osmotic laxatives are considered safe alternatives:
Lactulose
- Sugar-based osmotic laxative that is not absorbed systemically
- Recommended as first-line therapy during lactation 3
- Works by drawing water into the colon
- No significant transfer into breast milk
- Safe for breastfed infants
Macrogol (Polyethylene Glycol/PEG)
- Osmotic laxative that is not absorbed
- Recommended as first-line therapy during lactation, with some advantages over lactulose 3
- Faster onset of action and fewer flatulence side effects compared to lactulose
- No systemic absorption means no breast milk transfer
- Considered safe during breastfeeding
Third-Line Options: Stimulant Laxatives (Use with Caution)
If non-absorbed agents fail, stimulant laxatives may be considered:
Senna
- The American Academy of Pediatrics identifies senna as compatible with breastfeeding 1
- Low-certainty evidence suggests it increases the likelihood of bowel movements within 24 hours postpartum 4
- May cause abdominal cramping in the mother 4
- Minimal data on infant effects, but generally considered acceptable
Bisacodyl and Sodium Picosulfate
- Recommended during lactation when first-line therapies fail 3
- Diphenolic laxatives with minimal systemic absorption
- Should be used cautiously and for short durations
Agents to Avoid or Use with Extreme Caution
- Cascara: While listed by the AAP as compatible 1, it contains anthraquinones that may affect the infant
- Mineral oil: Though considered safe regarding lactation 3, it can interfere with absorption of fat-soluble vitamins
- Danthron: Should NOT be used - has carcinogenic properties 4
- Bisoxatin acetate: NOT recommended for lactating women 4
Practical Algorithm for Management
- Start with docusate sodium (stool softener) - safest option with no systemic absorption
- Add or switch to macrogol or lactulose if docusate insufficient - osmotic agents with no breast milk transfer
- Consider senna or bisacodyl only if osmotic laxatives fail - use shortest duration possible
- Combine with non-pharmacologic measures: Increase dietary fiber (bulk-forming agents like ispaghula/psyllium are safe as they're not absorbed) and fluid intake
Important Caveats
- Most gastrointestinal medications lack robust data on breast milk transfer 1, but non-absorbed agents are inherently safer
- The safest laxatives are those not absorbed systemically and should always be considered first-line 1
- Short-term use of most laxatives is generally low risk 1
- Monitor infants for potential gastrointestinal effects such as loose stools, diarrhea, or candidiasis, though these are rare with non-absorbed agents
- Always consult LactMed (National Library of Medicine database) for the most current safety information on specific medications 5, 6